A randomized, double-blinded, placebo-Controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BMS-986224 in healthy subjects and chronic heart failure patients with reduced ejection fraction

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2017
This article has no abstract
Epistemonikos ID: b15bb38767e9b609dadedd0f825ef1bb31229374
First added on: Apr 16, 2025